RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+43.99%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$2.32B
AUM Growth
+$2.32B
(+35%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
72.02%
Holding
31
New
6
Increased
4
Reduced
7
Closed
2
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$61.1M |
| 2 |
Axsome Therapeutics
AXSM
|
$46.9M |
| 3 |
Precision BioSciences
DTIL
|
$33.1M |
| 4 |
InflaRx
IFRX
|
$27.4M |
| 5 |
Alector
ALEC
|
$18.7M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$43.1M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$16.3M |
| 3 |
Arvinas
ARVN
|
$14.8M |
| 4 |
Ascendis Pharma
ASND
|
$12.7M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$3.99M |
Sector Composition
| 1 | Healthcare | 98.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ascendis Pharma
ASND
$11.8B
| $486M | 20.97% | 4,132,442 -108,094 | -3% | -$12.7M |
|
2
Wave Life Sciences
WVE
$1.53B
| $302M | 13.03% | 7,775,207 +263,158 | +4% | +$10.2M |
|
|
THOR
3
DELISTED
Synthorx, Inc. Common Stock
THOR
| $198M | 8.54% | 9,724,598 | – | – |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $131M | 5.65% | 2,382,168 | – | – |
|
|
RARX
5
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $109M | 4.69% | 4,858,260 | – | – |
|
|
6
InflaRx
IFRX
$108M
| $106M | 4.58% | 2,810,708 +725,619 | +35% | +$27.4M |
|
|
ORTX
7
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $91.3M | 3.94% | 5,108,330 +262,397 | +5% | +$4.69M |
|
|
EIDX
8
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $91.1M | 3.93% | 2,162,671 | – | – |
|
|
MYOV
9
DELISTED
Myovant Sciences Ltd.
MYOV
| $84.6M | 3.65% | 3,544,227 -167,322 | -5% | -$3.99M |
|
|
10
BioCryst Pharmaceuticals
BCRX
$1.74B
| $70.5M | 3.04% | 8,659,983 -2,000,366 | -19% | -$16.3M |
|
11
TG Therapeutics
TGTX
$4.65B
| $65.9M | 2.84% | 8,198,337 | – | – |
|
|
SAGE
12
DELISTED
Sage Therapeutics
SAGE
| $61.1M | 2.63% | +384,001 | New | +$61.1M |
|
13
Rhythm Pharmaceuticals
RYTM
$6.85B
| $51.7M | 2.23% | 1,884,782 -65,550 | -3% | -$1.8M |
|
|
14
Axsome Therapeutics
AXSM
$6.05B
| $46.9M | 2.02% | +3,293,789 | New | +$46.9M |
|
15
Crinetics Pharmaceuticals
CRNX
$2.92B
| $42.7M | 1.84% | 1,875,209 | – | – |
|
16
KalVista Pharmaceuticals
KALV
$678M
| $41.2M | 1.78% | 1,441,070 | – | – |
|
17
KALA BIO
KALA
$78.8M
| $37.5M | 1.62% | 4,537,478 | – | – |
|
|
MNTA
18
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $37.3M | 1.61% | 2,563,657 +5,300 | +0.2% | +$77K |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $36M | 1.55% | 2,456,669 | – | – |
|
|
EIGR
20
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $33.8M | 1.46% | 2,415,458 | – | – |
|
|
21
Precision BioSciences
DTIL
$57.8M
| $33.1M | 1.43% | +1,842,366 | New | +$33.1M |
|
|
22
Arvinas
ARVN
$568M
| $31.6M | 1.36% | 2,138,412 -1,000,000 | -32% | -$14.8M |
|
23
Moderna
MRNA
$9.37B
| $30.8M | 1.33% | 1,513,929 -397 | -0% | -$8.08K |
|
24
Iovance Biotherapeutics
IOVA
$807M
| $24.8M | 1.07% | 2,610,510 -109,942 | -4% | -$1.05M |
|
25
Solid Biosciences
SLDB
$427M
| $24.7M | 1.07% | 2,689,444 | – | – |
|